Globus Medical (GMED) Cash & Equivalents (2011 - 2026)
Globus Medical's (GMED) quarterly Cash & Equivalents came in at $560.9 million in Q1 2026, up 21.61% YoY from $461.3 million in Q1 2025, and up 6.61% on a QoQ basis from $526.2 million in Q4 2025.
Globus Medical (GMED) Cash & Equivalents (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has 16 years of Cash & Equivalents data on file, last reported at $560.9 million in Q1 2026.
- Quarterly Cash & Equivalents rose 21.61% year-over-year to $560.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $560.9 million (up 21.61% YoY) and the FY2025 annual result came in at $526.2 million, down 32.93% from the prior year.
- Cash & Equivalents improved to $560.9 million in Q1 2026, from $526.2 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $784.4 million in Q4 2024 to a low of $134.2 million in Q3 2022.
- A 5-year average of $368.1 million and a median of $354.1 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 62.91% — and 2023, when it jumped 210.56%.
- Tracing GMED's Cash & Equivalents over 5 years: stood at $150.5 million in 2022, then jumped by 210.56% to $467.3 million in 2023, then soared by 67.87% to $784.4 million in 2024, then plunged by 32.93% to $526.2 million in 2025, then grew by 6.61% to $560.9 million in 2026.
- The last three Cash & Equivalents figures came in at $560.9 million (Q1 2026), $526.2 million (Q4 2025), and $371.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Globus Medical | 11.66 Bn | 11.06 Bn | 548.17 Mn | 507.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 507.75 Mn |
| Mar 31, 2026 | 560.95 Mn |
| Dec 31, 2025 | 526.16 Mn |
| Sep 30, 2025 | 371.77 Mn |
| Jun 30, 2025 | 229.45 Mn |
| Mar 31, 2025 | 461.27 Mn |
| Dec 31, 2024 | 784.44 Mn |
| Sep 30, 2024 | 622.77 Mn |
| Jun 30, 2024 | 410.42 Mn |
| Mar 31, 2024 | 354.06 Mn |
| Dec 31, 2023 | 467.29 Mn |
| Sep 30, 2023 | 279.62 Mn |
| Jun 30, 2023 | 306.45 Mn |
| Mar 31, 2023 | 217.69 Mn |
| Dec 31, 2022 | 150.47 Mn |
| Sep 30, 2022 | 134.22 Mn |
| Jun 30, 2022 | 150.77 Mn |
| Mar 31, 2022 | 229.79 Mn |
| Dec 31, 2021 | 193.07 Mn |
| Sep 30, 2021 | 361.88 Mn |